FindTrial
Sign In

Clinical trial of jala neti and kapalabhati on Allergic Rhinitis

Effect of Jala Neti and Kapalabhati on Allergic Rhinitis(Pratishyaya)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/038028
Enrollment
120
Registered
2021-11-15
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

None listed

Sponsors

Department of Swasthavritta and Yoga Institute of Medical SciencesBHU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients showing and Symptoms of Allergic Rhinitis(Pratishyaya)

Exclusion criteria

Exclusion criteria: Epistaxis, nasal polyp, tumour, other chronic diseases, earlier nasal surgery, pregnant women, DNS.

Design outcomes

Primary

MeasureTime frame
T4SS (Total 4 Symptom Score) and (RQLQ) Rhino-conjunctivitis Quality of Life QuestionnaireTimepoint: Outcome will be done at baseline, and after 15 days, 1 month and 2 months—

Secondary

MeasureTime frame
Blood Test(CBC)Timepoint: Assessments will be done at baseline, and after 15 days, 1 month and 2 months—

Countries

India

Contacts

Public ContactRajesh Ranjan

Institute of Medical Sciences-BHU

nsneeru@yahoo.co.in9454187783

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026